Award
Delivery Order #SPE2DR26FDET0
Pharmaceutical Delivery Order for XOLAIR Autoinject by DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$13,979.52
Ceiling
$13,979.52
Awarded
February 26, 2026
Period of Performance
Feb 26, 2026 – Mar 19, 2026
Identifier
SPE2DR26FDET0
NAICS
424210
This award represents a delivery order under an existing indefinite delivery vehicle with DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical distribution and services. The contract involves procuring a specific pharmaceutical product: the XOLAIR 300 MG/2 ML autoinjector, used for treating certain medical conditions. This procurement is significant for maintaining the agency's access to essential medications, facilitating timely treatment options within public health programs. The scope encompasses the delivery of the specified pharmaceutical item to the location in Park Ridge, Illinois, within a short, defined timeframe. The order follows prior broad contracts with the same recipient, who is trusted for continued pharmaceutical supply under a long-term agreement. The contract was awarded through a streamlined process consistent with existing agreements, reflecting the urgency and specialized nature of the medication. The period of performance covers a brief window within the upcoming year, ensuring prompt fulfillment and availability of the medication for government healthcare needs.
Description
4571018818!XOLAIR 300 MG/2 ML AUTOINJECT 2ML